{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:01:40Z","timestamp":1649124100989},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Maria Curie-Sklodowska University in Lublin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00210-019-01640-3","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T04:46:34Z","timestamp":1552106794000},"page":"843-850","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Blebbistatin reveals beneficial effects on the cystometric parameters in an animal model of detrusor overactivity"],"prefix":"10.1007","volume":"392","author":[{"given":"Andrzej","family":"Wr\u00f3bel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urszula","family":"Doboszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Rechberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Ba\u0144czerowska-G\u00f3rska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edyta","family":"Wla\u017alak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Zakrocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Semczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Dudka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,9]]},"reference":[{"key":"1640_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.urology.2003.09.050","volume":"62","author":"P Abrams","year":"2003","unstructured":"Abrams P (2003) Describing bladder storage function: overactive bladder syndrome and detrusor overactivity. Urology 62:28\u201337","journal-title":"Urology"},{"key":"1640_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van KP, Victor A, Wein A (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37\u201349","journal-title":"Urology"},{"key":"1640_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1146\/annurev.bi.49.070180.004421","volume":"49","author":"RS Adelstein","year":"1980","unstructured":"Adelstein RS, Eisenberg E (1980) Regulation and kinetics of the actin-myosin-ATP interaction. Annu Rev Biochem 49:921\u2013956","journal-title":"Annu Rev Biochem"},{"key":"1640_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/sj.bjp.0706826","volume":"149","author":"M Alique","year":"2006","unstructured":"Alique M, Lucio FJ, Herrero JF (2006) Vitamin A active metabolite, all-trans retinoic acid, induces spinal cord sensitization. II. Effects after intrathecal administration. Br J Pharmacol 149:65\u201372","journal-title":"Br J Pharmacol"},{"key":"1640_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/iju.12954","volume":"23","author":"AA Al-Zahrani","year":"2016","unstructured":"Al-Zahrani AA, Gajewski J (2016) Urodynamic findings in women with refractory overactive bladder symptoms. Int J Urol 23:75\u201379","journal-title":"Int J Urol"},{"issue":"Suppl 3","key":"1640_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/bcpt.12577","volume":"119","author":"KE Andersson","year":"2016","unstructured":"Andersson KE (2016) Potential future pharmacological treatment of bladder dysfunction. Basic Clin Pharmacol Toxicol 119(Suppl 3):75\u201385","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1640_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1152\/physrev.00038.2003","volume":"84","author":"KE Andersson","year":"2004","unstructured":"Andersson KE, Arner A (2004) Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84:935\u2013986","journal-title":"Physiol Rev"},{"key":"1640_CR8","doi-asserted-by":"crossref","unstructured":"Arora PD, Di GM, He P, McCulloch CA (2017) TRPV4 mediates the Ca2+ influx required for the interaction between flightless-1 and non-muscle myosin, and collagen remodeling. J Cell Sci 130:2196\u20132208","DOI":"10.1242\/jcs.201665"},{"key":"1640_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E","volume":"50","author":"GJ Babu","year":"2000","unstructured":"Babu GJ, Warshaw DM, Periasamy M (2000) Smooth muscle myosin heavy chain isoforms and their role in muscle physiology. Microsc Res Tech 50:532\u2013540","journal-title":"Microsc Res Tech"},{"key":"1640_CR10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.eururo.2012.01.051","volume":"61","author":"D Behr-Roussel","year":"2012","unstructured":"Behr-Roussel D, Oger S, Pignol B, Pham E, Le MA, Chabrier PE, Caisey S, Compagnie S, Picaut P, Bernabe J, Alexandre L, Giuliano F, Denys P (2012) Minimal effective dose of dysport and botox in a rat model of neurogenic detrusor overactivity. Eur Urol 61:1054\u20131061","journal-title":"Eur Urol"},{"key":"1640_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/nau.22531","volume":"34","author":"L Boberg","year":"2015","unstructured":"Boberg L, Rahman A, Poljakovic M, Arner A (2015) Protein kinase C activation of a blebbistatin sensitive contractile component in the wall of hypertrophying mouse urinary bladder. Neurourol Urodyn 34:196\u2013202","journal-title":"Neurourol Urodyn"},{"key":"1640_CR12","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S0024-3205(01)01182-1","volume":"69","author":"TW Cannon","year":"2001","unstructured":"Cannon TW, Damaser MS (2001) Effects of anesthesia on cystometry and leak point pressure of the female rat. Life Sci 69:1193\u20131202","journal-title":"Life Sci"},{"key":"1640_CR13","doi-asserted-by":"publisher","first-page":"C1397","DOI":"10.1152\/ajpcell.00513.2002","volume":"285","author":"ME DiSanto","year":"2003","unstructured":"DiSanto ME, Stein R, Chang S, Hypolite JA, Zheng Y, Zderic S, Wein AJ, Chacko S (2003) Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am J Physiol Cell Physiol 285:C1397\u2013C1410","journal-title":"Am J Physiol Cell Physiol"},{"key":"1640_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1756287209350383","volume":"1","author":"RR Dmochowski","year":"2009","unstructured":"Dmochowski RR, Gomelsky A (2009) Overactive bladder in males. Ther Adv Urol 1:209\u2013221","journal-title":"Ther Adv Urol"},{"key":"1640_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1124\/jpet.106.109363","volume":"320","author":"TJ Eddinger","year":"2007","unstructured":"Eddinger TJ, Meer DP, Miner AS, Meehl J, Rovner AS, Ratz PH (2007) Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin. J Pharmacol Exp Ther 320:865\u2013870","journal-title":"J Pharmacol Exp Ther"},{"key":"1640_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.neuint.2009.07.011","volume":"55","author":"J El Andaloussi-Lilja","year":"2009","unstructured":"El Andaloussi-Lilja J, Lundqvist J, Forsby A (2009) TRPV1 expression and activity during retinoic acid-induced neuronal differentiation. Neurochem Int 55:768\u2013774","journal-title":"Neurochem Int"},{"key":"1640_CR17","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1073\/pnas.0506307103","volume":"103","author":"BJ Foth","year":"2006","unstructured":"Foth BJ, Goedecke MC, Soldati D (2006) New insights into myosin evolution and classification. Proc Natl Acad Sci U S A 103:3681\u20133686","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1640_CR18","doi-asserted-by":"publisher","first-page":"35557","DOI":"10.1074\/jbc.M405319200","volume":"279","author":"M Kovacs","year":"2004","unstructured":"Kovacs M, Toth J, Hetenyi C, Malnasi-Csizmadia A, Sellers JR (2004) Mechanism of blebbistatin inhibition of myosin II. J Biol Chem 279:35557\u201335563","journal-title":"J Biol Chem"},{"key":"1640_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000447205","volume":"11","author":"E Leron","year":"2018","unstructured":"Leron E, Weintraub AY, Mastrolia SA, Schwarzman P (2018) Overactive bladder syndrome: evaluation and management. Curr Urol 11:117\u2013125","journal-title":"Curr Urol"},{"key":"1640_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10974-004-6060-7","volume":"25","author":"J Limouze","year":"2004","unstructured":"Limouze J, Straight AF, Mitchison T, Sellers JR (2004) Specificity of blebbistatin, an inhibitor of myosin II. J Muscle Res Cell Motil 25:337\u2013341","journal-title":"J Muscle Res Cell Motil"},{"key":"1640_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/BF00370566","volume":"418","author":"U Malmqvist","year":"1991","unstructured":"Malmqvist U, Arner A (1991) Correlation between isoform composition of the 17\u00a0kDa myosin light chain and maximal shortening velocity in smooth muscle. Pflugers Arch 418:523\u2013530","journal-title":"Pflugers Arch"},{"key":"1640_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/35014065","volume":"2","author":"I Morano","year":"2000","unstructured":"Morano I, Chai GX, Baltas LG, Lamounier-Zepter V, Lutsch G, Kott M, Haase H, Bader M (2000) Smooth-muscle contraction without smooth-muscle myosin. Nat Cell Biol 2:371\u2013375","journal-title":"Nat Cell Biol"},{"key":"1640_CR23","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1242\/dmm.022103","volume":"8","author":"KA Newell-Litwa","year":"2015","unstructured":"Newell-Litwa KA, Horwitz R, Lamers ML (2015) Non-muscle myosin II in disease: mechanisms and therapeutic opportunities. Dis Model Mech 8:1495\u20131515","journal-title":"Dis Model Mech"},{"key":"1640_CR24","first-page":"844","volume":"83","author":"L Nowakowski","year":"2012","unstructured":"Nowakowski L, Kulik-Rechberger B, Wr\u00f3bel A, Rechberger T (2012) Overactive bladder\u2014a new insight into the pathogenesis of its idiopathic form. Ginekol Pol 83:844\u2013848","journal-title":"Ginekol Pol"},{"key":"1640_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.abb.2018.12.009","volume":"662","author":"PJ Reiser","year":"2018","unstructured":"Reiser PJ (2018) Current understanding of conventional and novel co-expression patterns of mammalian sarcomeric myosin heavy chains and light chains. Arch Biochem Biophys 662:129\u2013133","journal-title":"Arch Biochem Biophys"},{"key":"1640_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00424-006-0091-4","volume":"452","author":"AY Rhee","year":"2006","unstructured":"Rhee AY, Ogut O, Brozovich FV (2006) Nonmuscle myosin, force maintenance, and the tonic contractile phenotype in smooth muscle. Pflugers Arch 452:766\u2013774","journal-title":"Pflugers Arch"},{"key":"1640_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0167-4889(00)00005-7","volume":"1496","author":"JR Sellers","year":"2000","unstructured":"Sellers JR (2000) Myosins: a diverse superfamily. Biochim Biophys Acta 1496:3\u201322","journal-title":"Biochim Biophys Acta"},{"key":"1640_CR28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1742-1241.2010.02626.x","volume":"65","author":"CC Sexton","year":"2011","unstructured":"Sexton CC, Notte SM, Maroulis C, Dmochowski RR, Cardozo L, Subramanian D, Coyne KS (2011) Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract 65:567\u2013585","journal-title":"Int J Clin Pract"},{"key":"1640_CR29","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1126\/science.1081412","volume":"299","author":"AF Straight","year":"2003","unstructured":"Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR, Mitchison TJ (2003) Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science 299:1743\u20131747","journal-title":"Science"},{"key":"1640_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-011110-130303","volume":"6","author":"XH Tang","year":"2011","unstructured":"Tang XH, Gudas LJ (2011) Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol 6:345\u2013364","journal-title":"Annu Rev Pathol"},{"key":"1640_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/14656566.2016.1186645","volume":"17","author":"G Thiagamoorthy","year":"2016","unstructured":"Thiagamoorthy G, Cardozo L, Robinson D (2016) Current and future pharmacotherapy for treating overactive bladder. Expert Opin Pharmacother 17:1317\u20131325","journal-title":"Expert Opin Pharmacother"},{"key":"1640_CR32","doi-asserted-by":"crossref","unstructured":"Wr\u00f3bel A, Rechberger T (2017a) The effect of combined treatment with a \u03b23 AR agonist and a ROCK inhibitor on detrusor overactivity. Neurourol Urodyn 36:580\u2013588","DOI":"10.1002\/nau.22978"},{"key":"1640_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/nau.22918","volume":"36","author":"A Wr\u00f3bel","year":"2017","unstructured":"Wr\u00f3bel A, Rechberger T (2017b) The influence of Rho-kinase inhibition on acetic acid-induced detrusor overactivity. Neurourol Urodyn 36:263\u2013270","journal-title":"Neurourol Urodyn"},{"key":"1640_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.vascn.2015.04.006","volume":"74","author":"A Wr\u00f3bel","year":"2015","unstructured":"Wr\u00f3bel A, \u0141a\u0144cut M, Rechberger T (2015) A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation. J Pharmacol Toxicol Methods 74:7\u201316","journal-title":"J Pharmacol Toxicol Methods"},{"key":"1640_CR35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00210-017-1361-8","volume":"390","author":"A Wr\u00f3bel","year":"2017","unstructured":"Wr\u00f3bel A, Doboszewska U, Rechberger E, Rojek K, Serefko A, Poleszak E, Skalicka-Wo\u017aniak K, Dudka J, Wla\u017a P (2017) Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats. Naunyn Schmiedeberg\u2019s Arch Pharmacol 390:613\u2013619","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1640_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12640-018-9948-5","volume":"35","author":"A Wr\u00f3bel","year":"2019","unstructured":"Wr\u00f3bel A, Doboszewska U, Rechberger E, Ba\u0144czerowska-G\u00f3rska M, Czuczwar P, Poleszak E, Dudka J, Wla\u017a P, Miot\u0142a P, Wla\u017alak E, Rechberger T (2019) Blebbistatin, a myosin II inhibitor, exerts antidepressant-like activity and suppresses detrusor overactivity in an animal model of depression coexisting with overactive bladder. Neurotox Res 35:196\u2013207","journal-title":"Neurotox Res"},{"key":"1640_CR37","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1172\/JCI66413","volume":"123","author":"S Yin","year":"2013","unstructured":"Yin S, Luo J, Qian A, Du J, Yang Q, Zhou S, Yu W, Du G, Clark RB, Walters ET, Carlton SM, Hu H (2013) Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity. J Clin Invest 123:3941\u20133951","journal-title":"J Clin Invest"},{"key":"1640_CR38","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/mp.2015.103","volume":"21","author":"EJ Young","year":"2016","unstructured":"Young EJ, Blouin AM, Briggs SB, Sillivan SE, Lin L, Cameron MD, Rumbaugh G, Miller CA (2016) Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use. Mol Psychiatry 21:615\u2013623","journal-title":"Mol Psychiatry"},{"key":"1640_CR39","first-page":"169","volume":"7","author":"MM Zacche","year":"2015","unstructured":"Zacche MM, Srikrishna S, Cardozo L (2015) Novel targeted bladder drug-delivery systems: a review. Res Rep Urol 7:169\u2013178","journal-title":"Res Rep Urol"},{"key":"1640_CR40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1464-410X.2010.09366.x","volume":"107","author":"X Zhang","year":"2011","unstructured":"Zhang X, Kuppam DS, Melman A, DiSanto ME (2011a) In vitro and in vivo relaxation of urinary bladder smooth muscle by the selective myosin II inhibitor, blebbistatin. BJU Int 107:310\u2013317","journal-title":"BJU Int"},{"key":"1640_CR41","doi-asserted-by":"publisher","first-page":"e25958","DOI":"10.1371\/journal.pone.0025958","volume":"6","author":"X Zhang","year":"2011","unstructured":"Zhang X, Seftel A, DiSanto ME (2011b) Blebbistatin, a myosin II inhibitor, as a novel strategy to regulate detrusor contractility in a rat model of partial bladder outlet obstruction. PLoS One 6:e25958","journal-title":"PLoS One"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01640-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-019-01640-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01640-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T14:13:15Z","timestamp":1592230395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-019-01640-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,9]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1007\/s00210-019-01640-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,9]]},"assertion":[{"value":"25 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed following the European Communities Council Directive of 22 September 2010 (2010\/63\/EU). The experimental procedures and protocols were approved by the Local Ethics Committee (Lublin, Poland).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The funding source had no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"All authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}